Our findings demonstrate that SOX2 protein expression and gene amplification are frequent events in laryngeal tumorigenesis and, more importantly, both emerge as clinically and biologically relevant features in laryngeal cancer development. This evidence concerns the gene SOX2 and laryngeal carcinoma.